biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Man! Interest In This Stock Is Jumping!

<< Previous

Bullboard Posts

Next >>

Comment by Finallytherockon Jul 16, 2021 11:45am

119 Views

Post# 33559695

RE:RE:RE:Man! Interest In This Stock Is Jumping!

Unfortunately it's "maybe". Given the history of this company, shareholders are likely cautious and reserved as to anything substantial happening. I'd love for it to happen but I think keeping expectations very low is probably a good thing

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs